Compliance Rate

Compliance Rate 100.0%
Compliant submissions 1
Incompliant submissions 0
Total trials 1

My Organizations' Clinical Trials

Showing 75 of 715 entries
View as:

Efficacy and Safety of Diclofenac Diethylamine 2.32% Gel in Patients With Acute Ankle Sprain

Phase: N/A Priority: Normal
NCT ID: NCT00573768 Org: User:
Start: 11/30/07 End: 07/31/08 Due: 07/31/09

Follow-up Study of Safety of Enteric-coated Mycophenolate Sodium in Patients Who Successfully Completed Study CERL080A301

Phase: N/A Priority: Normal
NCT ID: NCT00149929 Org: User:
Start: 12/31/99 End: 04/30/03 Due: 04/30/04

Heart Failure Therapy and Outcomes in Patients With Heart Failure With Mildly Reduced or Preserved Ejection Fraction

Phase: N/A Priority: Normal
NCT ID: NCT06671314 Org: User:
Start: 06/02/22 End: 10/31/22 Due: 10/31/23

Efficacy and Safety of Combination Therapy of Vildagliptin/Metformin in Patients in Type 2 Diabetes Mellitus (T2DM)

Phase: N/A Priority: Normal
NCT ID: NCT01196546 Org: User:
Start: 03/31/10 End: 10/31/11 Due: 10/31/12

A Clinical Study to Compare Long-term Efficacy and Safety of an Aliskiren Based Regimen to a Hydrochlorothiazide Based Treatment Regimen With Optional Addition of Amlodipine

Phase: N/A Priority: Normal
NCT ID: NCT00294710 Org: User:
Start: 03/31/05 End: 07/31/06 Due: 07/31/07

Safety and Immunogenicity of Two Doses, Administered Three Weeks Apart, of Two(Surface Antigen Adjuvanted With MF59C.1) Influenza Vaccines in Non-Elderly Adult and Elderly Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00311480 Org: User:
Start: 03/31/06 End: - Due: -

Post-marketing Study to Collect Safety Data in Heart Transplant Patients Receiving Everolimus

Phase: N/A Priority: Normal
NCT ID: NCT00134940 Org: User:
Start: 01/31/05 End: 11/30/06 Due: 11/30/07

Feasibility and Reproducibility of Barostat Assessments of Colorectal Sensation During Colorectal Distention and Its Pharmacological Modulation Using Octreotide

Phase: N/A Priority: Normal
NCT ID: NCT00584298 Org: User:
Start: 01/31/08 End: - Due: -

Long-Term Study of IGE025 in Moderate to Severe Bronchial Asthma.

Phase: N/A Priority: Normal
NCT ID: NCT00219323 Org: User:
Start: 11/30/03 End: 03/31/06 Due: 03/31/07

Effect of Treatment With Fingolimod on the Immune Response Following Seasonal Flu Vaccination and Tetanus Booster Injection in Patients With Relapsing Multiple Sclerosis (MS)

Phase: N/A Priority: Normal
NCT ID: NCT01199861 Org: User:
Start: 08/31/10 End: 05/31/11 Due: 05/31/12

Efficacy of BGG492 in Individuals With Refractory Partial Seizures Undergoing Inpatient Evaluation for Epilepsy Surgery

Phase: N/A Priority: Normal
NCT ID: NCT00887861 Org: User:
Start: 03/31/09 End: 08/31/10 Due: 08/31/11

Safety and Immunogenicity of a Commercially Available Influenza Vaccine (Formulation 2006/2007) When Administered to Elderly Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00329927 Org: User:
Start: 06/30/06 End: - Due: -

Effects of AFQ056 and Baclofen on Meal-Induced Gastroesophageal Reflux

Phase: N/A Priority: Normal
NCT ID: NCT00414856 Org: User:
Start: 08/31/06 End: - Due: -

Efficacy and Safety of Diclofenac Sodium Topical Gel 1% Applied 4 Times Daily in Subjects With Acute Ankle Sprain

Phase: N/A Priority: Normal
NCT ID: NCT01255423 Org: User:
Start: 11/30/10 End: 06/30/11 Due: 06/30/12

Safety and Blood Donations in Adults Vaccinated With rMenB+OMV NZ.

Phase: N/A Priority: Normal
NCT ID: NCT02305446 Org: User:
Start: 12/31/14 End: 04/30/15 Due: 04/30/16

Proof-of-concept for the Aldosterone Synthase Inhibitor LCI699 in Patients With Primary Hyperaldosteronism

Phase: N/A Priority: Normal
NCT ID: NCT00732771 Org: User:
Start: 06/30/08 End: - Due: -

Safety and Immunogenicity of Two 0.25 mL or 0.5 mL Doses of Two Different Influenza Vaccines in Healthy Children Aged 6 to <60 Months

Phase: N/A Priority: Normal
NCT ID: NCT00649883 Org: User:
Start: 01/31/08 End: 10/31/08 Due: 10/31/09

Efficacy and Safety of Valsartan/Hydrochlorothiazide Combination Therapy in Patients With Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT00277472 Org: User:
Start: 11/30/05 End: - Due: -

A Study to Assess the Efficacy, Safety and Tolerability of Tegaserod Alone and in Combination With Omeprazole Given Orally in Patients With Symptoms of Symptomatic Gastroesophageal Reflux Disease (sGERD)

Phase: N/A Priority: Normal
NCT ID: NCT00149851 Org: User:
Start: 01/31/04 End: 06/30/05 Due: 06/30/06

Conversion Trial From Mycophenolate Mofetil (MMF) to Enteric-coated Mycophenolate Sodium (EC-MPS) in Stable Transplanted Patients Suffering From Gastrointestinal (GI) Adverse Events While on Mycophenolate Mofetil Therapy (MMF) Therapy

Phase: N/A Priority: Normal
NCT ID: NCT00149942 Org: User:
Start: 10/31/04 End: 08/31/06 Due: 08/31/07

Safety and Efficacy of Aliskiren in Post Myocardial Infarction Patients (ASPIRE)

Phase: N/A Priority: Normal
NCT ID: NCT00414609 Org: User:
Start: 12/31/06 End: 07/31/11 Due: 07/31/12

Certoparin in Renal Patients Undergoing Hemodialysis

Phase: N/A Priority: Normal
NCT ID: NCT01179620 Org: User:
Start: 11/30/10 End: 03/31/11 Due: 03/31/12

Clinical Effectiveness of 10 cm^2 Rivastigmine Patch in Patients With Alzheimer's Disease

Phase: N/A Priority: Normal
NCT ID: NCT00561392 Org: User:
Start: 11/30/07 End: 11/30/08 Due: 11/30/09

A Real-world Study of Inclisiran Adherence, Treatment Patterns, Patient Characteristics, and Effectiveness in ASCVD Patients With Hypercholesterolemia, ASCVD-risk Equivalent Patients With Hypercholesterolemia and Familial Hypercholesterolemia

Phase: N/A Priority: Normal
NCT ID: NCT06507852 Org: User:
Start: 10/03/22 End: 07/06/23 Due: 07/06/24

A Study To Compare the Effect of Vildagliptin Compared to Placebo in Patients With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT00351832 Org: User:
Start: 06/30/06 End: - Due: -